Ana Martı́nez

18.4k total citations
461 papers, 12.3k citations indexed

About

Ana Martı́nez is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Ana Martı́nez has authored 461 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Molecular Biology, 143 papers in Organic Chemistry and 85 papers in Pharmacology. Recurrent topics in Ana Martı́nez's work include Cholinesterase and Neurodegenerative Diseases (76 papers), Phosphodiesterase function and regulation (42 papers) and Computational Drug Discovery Methods (40 papers). Ana Martı́nez is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (76 papers), Phosphodiesterase function and regulation (42 papers) and Computational Drug Discovery Methods (40 papers). Ana Martı́nez collaborates with scholars based in Spain, United States and Germany. Ana Martı́nez's co-authors include Ana Castro, Carmen Gil, Daniel I. Pérez, Concepción Pérez, Mercedes Alonso, Valle Palomo, Isabel Dorronsoro, Hagit Eldar-Finkelman, Ana Pérez‐Castillo and Nuria E. Campillo and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Ana Martı́nez

438 papers receiving 12.1k citations

Peers

Countries citing papers authored by Ana Martı́nez

Since Specialization

Citations

This map shows the geographic impact of Ana Martı́nez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Martı́nez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Martı́nez more than expected).

Fields of papers citing papers by Ana Martı́nez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Martı́nez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Martı́nez. The network helps show where Ana Martı́nez may publish in the future.

Co-authorship network of co-authors of Ana Martı́nez

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Martı́nez. A scholar is included among the top collaborators of Ana Martı́nez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Martı́nez. Ana Martı́nez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers 2025 ·Neurobiology of Disease ·Eva P. Cuevas, Enrique López Madruga, (unknown), David Ramírez, Carmen Gil, Siranjeevi Nagaraj, Ángeles Martín‐Requero, Ana Martı́nez	2
2	Structure-Based Discovery Targeting GSK-3α Reveals Potent Nanomolar Selective 4-Phenyl-1H-benzofuro[3,2-b]pyrazolo[4,3-e]pyridine Inhibitor with Promising Glioblastoma and CNS-Active Potential in Cellular Models 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jane Alder, (unknown), Erwin Berenschot, Niels R. Tas, Arturo Susarrey‐Arce, Loreto Martínez‐González, Alina Oknianska, (unknown), Ana Martı́nez, Joseph M. Hayes	0
3	Small molecule inhibitors of human LRRK2 enhance in vitro embryogenesis and microcallus formation for plant regeneration of crop and model species 2024 ·Journal of Plant Physiology ·Elena Carneros, (unknown), (unknown), (unknown), Ralf Welsch, Klaus Palme, Carmen Gil, Ana Martı́nez, Pilar S. Testillano	1
4	Effectiveness of Influenza Vaccination and Early Antiviral Treatment in Reducing Pneumonia Risk in Severe Influenza Cases 2024 ·Vaccines ·Pere Godoy, Núria Soldevila, Ana Martı́nez, (unknown), Mireia Jané, Núria Torner, (unknown), Cristina Rius, Ángela Domı́nguez	3
5	Hepatitis B Virus-Related Cirrhosis and Hepatocellular Carcinoma Hospital Discharge Rates from 2005 to 2021 in Spain: Impact of Universal Vaccination 2024 ·Vaccines ·Ángela Domı́nguez, Ana Avellón, Víctoria Hernando, Núria Soldevila, Eva Borrás, Ana Martı́nez, Conchita Izquierdo, Núria Torner, (unknown), Cristina Rius, Pere Godoy	2
6	Impact of the Universal Implementation of Adolescent Hepatitis B Vaccination in Spain 2024 ·Vaccines ·Ángela Domı́nguez, Ana Avellón, Víctoria Hernando, Núria Soldevila, Eva Borrás, Ana Martı́nez, Conchita Izquierdo, Núria Torner, (unknown), Cristina Rius, Pere Godoy	1
7	TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients 2023 ·Frontiers in Molecular Neuroscience ·Loreto Martínez‐González, Eva P. Cuevas, (unknown), Vanesa Nozal, Carmen Gil, Valle Palomo, Ángeles Martín‐Requero, Ana Martı́nez	9
8	Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Inés Maestro, Enrique López Madruga, Patricia Boya, Ana Martı́nez	9
9	The mechanism of macroautophagy: The movie 2022 ·SHILAP Revista de lepidopterología ·Fulvio Reggiori, Patricia Boya, David Da Costa, Zvulun Elazar, Eeva‐Liisa Eskelinen, Judith Farrés, Sebastian Guettler, Claudine Kraft, Heinz Jungbluth, Ana Martı́nez, Étienne Morel, Ole Pleß, Tassula Proikas‐Cezanne, Anne Simonsen	1
10	Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis 2022 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Geoffrey Wells, (unknown), Ángeles Martín‐Requero, (unknown), Ana Martı́nez, Giorgio Giorgi, Pilar López‐Alvarado, Isabel Lastres‐Becker, J. Carlos Menéndez	17
11	Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy 2021 ·International Journal of Molecular Sciences ·Isabel Lastres‐Becker, (unknown), Marina Arribas-Blázquez, Inés Maestro, (unknown), Patricia Boya, Sebastián Cerdán, Alberto García‐Redondo, Ana Martı́nez, Ángeles Martín‐Requero	22
12	Targeting autophagy in disease: established and new strategies 2021 ·Autophagy ·Muhammed Koçak, (unknown), (unknown), Inés Maestro, Judith Farrés, Vladimir Kirkin, Ana Martı́nez, Ole Pleß	139
13	Serum- and glucocorticoid-induced kinase 1, a new therapeutic target for autophagy modulation in chronic diseases 2020 ·Expert Opinion on Therapeutic Targets ·Inés Maestro, Patricia Boya, Ana Martı́nez	15
14	From simple quinoxalines to potent oxazolo[5,4-f]quinoxaline inhibitors of glycogen-synthase kinase 3 (GSK3) 2019 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), Carlos Roca, Concepción Pérez, Ana Martı́nez, Blandine Baratte, Thomas Robert, Sandrine Ruchaud, Stéphane Bach, William Erb, Thierry Roisnel, Florence Mongin	11
15	Driving next-generation autophagy researchers towards translation (DRIVE), an international PhD training program on autophagy 2018 ·Autophagy ·Claudine Kraft, Patricia Boya, Patrice Codogno, Zvulun Elazar, Eeva‐Liisa Eskelinen, Judith Farrés, Vladimir Kirkin, Heinz Jungbluth, Ana Martı́nez, Ole Pleß, Charlotte Primard, Tassula Proikas‐Cezanne, Anne Simonsen, Fulvio Reggiori	4
16	Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease 2018 ·Bioorganic & Medicinal Chemistry ·Peterson de Andrade, (unknown), (unknown), Carlos Roca, Concepción Pérez, Danilo J. Xavier, Elza Tiemi Sakamoto‐Hojo, Nuria E. Campillo, Ana Martı́nez, Ivone Carvalho	37
17	Inhibition of glycogen synthase kinase 3 prevents synaptic long-term depression and facilitates cognition in C57BL/6J mice 2016 ·Tatiana V. Lipina, (unknown), (unknown), (unknown), Valle Palomo, Daniel I. Pérez, Ana Martı́nez, John Roder	3
18	The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injury 2012 ·Journal of Neurochemistry ·Cristina Susín, José Á. Morales-García, Diana Aguilar‐Morante, Valle Palomo, Marina Sanz-SanCristóbal, Sandra Alonso‐Gil, Carmen Gil, Ángel Santos, Ana Martı́nez, Ana Pérez‐Castillo	16
19	Brotes escolares de gripe (H1N1) 2009 en Cataluña 2011 ·Revista Española de Salud Pública ·Núria Torner, (unknown), Ana Martı́nez, Pere Godoy	2
20	Absence of Sustained Hyperlactatemia in HIV-Infected Patients With Risk Factors for Mitochondrial Toxicity 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·David A. Wohl, Christopher D. Pilcher, Scott B. Evans, (unknown), Grace A. McComsey, Yijun Yang, Robert Zackin, Beverly Alston, (unknown), Michael Basar, Angela D. M. Kashuba, (unknown), Ana Martı́nez, (unknown), Joseph Quinn, (unknown), (unknown), Susan L. Koletar	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact